发明授权
US08071586B2 Heterocyclyl compounds 失效
杂环化合物

Heterocyclyl compounds
摘要:
The invention is concerned with novel heterocyclyl compounds of formula (I) wherein A, X, Y1, Y2, Y3, R3, R4, R5, R6, R7, R8, R9, R10, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.
公开/授权文献
信息查询
0/0